< Back to search
Filter
1

Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Norfolk VA, Greenville SC, Kettering OH, Yakima WA,
Sponsor: Cylene Pharmaceuticals

Sex: All

Age: 18+

Code: NCT01199718

Phase1, Recruiting

A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study

for
Neoplasms, Plasma Cell, Neoplasms by Histologic Type, Neoplasms,
Location: Atlanta GA
Sponsor: OriCell Therapeutics Co., Ltd.

Sex: All

Age: 18 - 70+

Code: NCT06271252

Phase1, Recruiting

Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma

for
Refractory Multiple Myeloma
Location: Ottawa, Kingston, Hamilton, London, Vancouver
Sponsor: Ontario Clinical Oncology Group (OCOG)

Sex: All

Age: 18+

Code: NCT06421675

Phase2, Recruiting

CPAP for the Treatment of Supine Hypertension

for
Autonomic Failure, Pure Autonomic Failure,
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 40 - 70+

Code: NCT05489575

Recruiting

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

for
Multiple Myeloma
Location: Montreal, Deerfield Beach FL, Miami FL, Coral Gables FL,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06057402

Recruiting

Interested in new multiple sclerosis trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Sleep Apnea in Patients With MGUS and MM

for
Multiple Myeloma,
Location: Iowa City IA
Sponsor: Michael Tomasson

Sex: All

Age: 18 - 70+

Code: NCT04114084

Recruiting

A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events

for
Multiple Myeloma
Location: New Haven CT, New York NY, Richmond VA, Rochester NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06500884

Phase2, Recruiting

Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma

for
Relapsed and Refractory Multiple Myeloma
Location: Deerfield Beach FL, Miami FL, Coral Gables FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT05530421

Phase2, Recruiting

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

for
Lymphoma, Leukemia, Multiple Myeloma, Colon Cancer,
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 0+

Code: NCT00582621

Recruiting

Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS

for
Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS),
Location: Philadelphia PA, Hershey PA, Washington D.C. DC,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 0 - 17

Code: NCT05267821

Phase2, Phase3, Recruiting

A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

for
Relapsed Refractory Multiple Myeloma (RRMM)
Location: Durham NC
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05730036

Phase3, Recruiting

CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)

for
Cancer, Malignancies Multiple, Malignant Solid Tumor,
Location: Halifax, Fredericton, Sherbrooke, Montreal, Ottawa,
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT04151342

Recruiting

Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma

for
Multiple Myeloma
Location: West Hollywood CA
Sponsor: Oncotherapeutics

Sex: All

Age: 18+

Code: NCT06209606

Early_phase1, Recruiting

Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)

for
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors
Location: Montreal, Ottawa, Kingston, Toronto, London, Regina,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT03297606

Phase2, Recruiting

Personalized Autologous Transplant for Multiple Myeloma

for
Multiple Myeloma
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT04483206

Phase1, Recruiting

Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma

for
Recurrent Multiple Myeloma, Refractory Multiple Myeloma
Location: Guilford CT, North Haven CT, New Haven CT, Derby CT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06465316

Phase1, Recruiting

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

for
Relapsed or Refractory Multiple Myeloma,
Location: New York NY, Philadelphia PA, Charlotte NC, Houston TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05652335

Phase1, Recruiting

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

for
Monoclonal Gammopathy of Undetermined Significance (MGUS),
Location: Boston MA, Stony Brook NY, New York NY, Philadelphia PA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06140524

Phase2, Recruiting

ATRA and Carfilzomib in Plasma Cell Myeloma Patients

for
Multiple Myeloma
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute

Sex: All

Age: 18+

Code: NCT06536413

Phase1, Phase2, Recruiting

Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan

for
Multiple Myeloma, Autologous Stem Cell Transplantation
Location: Augusta GA
Sponsor: Augusta University

Sex: All

Age: 18+

Code: NCT06588413

Phase3, Recruiting